Severe neurological disorders and vascular events during COVID-19 have been described. Here, we describe the first case of a female patient infected with the SARS-CoV-2 BA.2 Omicron variant of concern with meningitis with newly diagnosed central demyelinating disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468051PMC
http://dx.doi.org/10.1016/j.ijid.2022.09.011DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 ba2
8
case meningitis
4
meningitis associated
4
associated sars-cov-2
4
ba2 variant
4
variant infection
4
infection persistent
4
persistent viremia
4
viremia severe
4
severe neurological
4

Similar Publications

Coronavirus Disease 2019 (COVID-19) emerged in December 2019, prompting the implementation of a "zero-COVID" policy in Mainland China. The easing of this policy in December 2022 led to a surge in COVID cases, which was believed to significantly increase antibiotic usage, potentially due to antibiotic misuse or increased coinfections. Our study aimed to compare antibiotic consumption and patterns before and after this policy adjustment.

View Article and Find Full Text PDF

Personal care products use during SARS-CoV-2 pandemic: Environmental and public health impact assessment using wastewater-based epidemiology.

Water Res

January 2025

Department of Chemistry, University of Bath, Bath BA2 7AY, UK; Institute for Sustainability, University of Bath, Bath BA2 7AY, UK; Centre of Excellence in Water Based Early Warning Systems for Health Protection, University of Bath, Bath BA2 7AY, UK. Electronic address:

The recent SARS-CoV-2 pandemic had profound consequences on people's wellbeing, societies and economy worldwide. This manuscript discusses public exposure to chemicals of concern in personal care products (parabens and benzophenones) during SARS-CoV-2 pandemic. These were monitored for two years in four catchments (two cities and two towns) in South West England accounting for >1 million people.

View Article and Find Full Text PDF

: The rapid spread of the COVID-19 pandemic has had a significant impact on the psychological well-being of millions of people around the world, and even more so among children. Contracting SARS-CoV-2, resulting in home confinement and restrictions on daily and school activities, led to negative effects on the mental health of the paediatric population. Although children suffering from COVID-19 had milder general symptoms compared to adults, impairments in cognitive, neuropsychological, and emotional-behavioural development were noted.

View Article and Find Full Text PDF
Article Synopsis
  • Research shows that T cell responses to the SARS-CoV-2 spike protein were significantly boosted in vaccinated individuals after the omicron surge, suggesting many had asymptomatic infections.
  • In a study of 216 individuals, those fully vaccinated with two doses exhibited T cell responses comparable to those who had recovered from COVID-19 or received booster shots, following exposure to omicron.
  • The findings also revealed strong T cell reactivity against various omicron sub-variants, indicating that the immune system can effectively respond to new strains even after vaccination.
View Article and Find Full Text PDF

Background: According to Norwegian registries, 91% of individuals ≥ 16 years had received ≥ 1 dose of COVID-19 vaccine by mid-July 2022, whereas less than 2% of children < 12 years were vaccinated. Confirmed COVID-19 was reported for 27% of the population, but relaxation of testing lead to substantial underreporting. We have characterized the humoral immunity to SARS-CoV-2 in Norway in the late summer of 2022 by estimating the seroprevalence and identifying antibody profiles based on reactivity to Wuhan or Omicron-like viruses in a nationwide cross-sectional collection of residual sera, and validated our findings using cohort sera.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!